Across the recent three months, 11 analysts have shared their insights on BioNTech (NASDAQ:BNTX), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 4 | 1 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 2 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.55, a high estimate of $171.00, and a low estimate of $90.00. This current average has increased by 1.79% from the previous average price target of $110.57.
Deciphering Analyst Ratings: An In-Depth Analysis
In examining recent...
Login or create a forever free account to read this news
Sign up/Log in